HEPA · Hepion Pharmaceuticals, Inc.

$0.05 +0.00 (+2.22%) At close · Jul 30

Market Cap

$1.34M

29.12M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-07-01	Fisher Danina	Director	Other↑	No Securities Owned	0	—	—	0
2026-07-01	Stetz Gary S. II	Director	Other↑	No Securities Owned	0	—	—	0
2026-04-21	LoPriore Vincent S	Director, Executive Chairman	Buy↑ Filing footnotes — Common Stock, par value $0.0001 per share (Indirect) Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.	Common Stock, par value $0.0001 per share (I)	5,000,000	$0.04	$200,000	5,000,000
2026-04-21	Stetz Gary S.	Director, Chief Executive Officer	Buy↑ Filing footnotes — Common Stock, par value $0.0001 per share (Indirect) Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz	Common Stock, par value $0.0001 per share (I)	1,250,000	$0.04	$50,000	1,250,000
2026-04-21	Appajosyula Sireesh	Director	Buy↑	Common Stock, par value $0.0001 per share	1,250,000	$0.04	$50,000	1,250,000
2026-04-21	LoPriore Vincent S	Director, Executive Chairman	Buy↑ Filing footnotes — Common Stock, par value $0.0001 per share (Indirect) Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.	Common Stock, par value $0.0001 per share (I)	1,250,000	$0.04	$50,000	6,250,000
2026-04-21	Purcell Michael J.	Director	Buy↑	Common Stock, par value $0.0001 per share	1,250,000	$0.04	$50,000	1,250,000
2026-03-16	LoPriore Vincent S	Director, Executive Chairman	Other↑	No Securities Owned	0	—	—	0
2026-03-16	Appajosyula Sireesh	Director	Other↑	No Securities Owned	0	—	—	0
2026-03-16	Stetz Gary S.	Director, Chief Executive Officer	Other↑	No Securities Owned	0	—	—	0
2024-03-06	Purcell Michael J.	Director	Award↑ Filing footnotes — Restricted Stock Units (Direct) The Reporting Person was granted restricted stock units (RSU's) which represent a contingent right to receive one share of Common Stock for each RSU. Upon the earlier of (i) one year from date of grant or (ii) a change of control of the Issuer.	Restricted Stock Units	50,000	—	—	1,000
2024-03-05	Purcell Michael J.	Director	Other↑	No Securities Owned	0	—	—	0
2024-02-19	Lbiati Kaouthar	Director	Award↑	Stock Options	85,000	—	—	1,760
2024-02-19	BRANCACCIO JOHN P	Director	Award↑	Stock Options	85,000	—	—	1,991
2024-02-19	Block Timothy M.	Director	Award↑	Stock Options	85,000	—	—	1,991
2024-02-19	JACOB GARY S	Director	Award↑	Stock Options	85,000	—	—	2,042
2023-11-27	Wijngaard Peter	Director	Buy↑	Common Stock	2,500	$3.05	$7,625	190
2023-11-24	Wijngaard Peter	Director	Buy↑	Common Stock	2,500	$3.09	$7,725	140
2023-09-19	Wijngaard Peter	Director	Buy↑	Common Stock	1,000	$5.64	$5,640	90
2023-09-18	Foster Robert T	Director	Buy↑	Common Stock	1,600	$5.60	$8,960	1,009
2023-09-15	Wijngaard Peter	Director	Buy↑	Common Stock	139	$5.45	$758	53
2023-09-15	Foster Robert T	Director	Buy↑	Common Stock	1,600	$5.40	$8,640	977
2023-09-15	Wijngaard Peter	Director	Buy↑	Common Stock	861	$5.37	$4,624	70
2023-09-15	Wijngaard Peter	Director	Buy↑	Common Stock	1,000	$5.82	$5,820	50
2021-05-18	Wijngaard Peter	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	200,000	—	—	260
2021-05-18	Block Timothy M.	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	200,000	—	—	291
2021-05-18	ADAMS THOMAS PHD	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	200,000	—	—	291
2021-05-18	Cavan John T	Chief Financial Officer	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan. 400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.	Stock Options	1,200,000	—	—	1,581
2021-05-18	Lippa Arnold	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	200,000	—	—	291
2021-05-18	BRANCACCIO JOHN P	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	200,000	—	—	291
2021-05-18	JACOB GARY S	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.	Stock Options	250,000	—	—	343
2021-05-18	Foster Robert T	Director	Award↑ Filing footnotes — Stock Options (Direct) Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan. 633,333 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.	Stock Options	1,900,000	—	—	2,502
2021-02-18	Foster Robert T	Director	Buy↑	Common Stock	20,000	$2.00	$40,000	45
2021-02-18	Cavan John T	Chief Financial Officer	Buy↑	Common Stock	10,000	$2.00	$20,000	15
2021-02-16	Wijngaard Peter	Director	Buy↑	Common Stock	10,000	$2.20	$22,000	30
2020-12-18	Wijngaard Peter	Director	Buy↑	Common Stock	20,000	$1.91	$38,200	20
2020-12-08	Foster Robert T	Director	Buy↑	Common Stock	25,000	$1.58	$39,418	25
2020-12-02	BRANCACCIO JOHN P	Director	Buy↑	Common Stock	7,000	$1.53	$10,710	7
2020-12-01	JACOB GARY S	Director	Buy↑	Common Stock	12,000	$1.66	$19,920	12
2020-11-25	Cavan John T	Chief Financial Officer	Buy↑	Common Stock	4,500	$1.62	$7,290	5
2020-08-19	Lippa Arnold	Director	Award↑	Stock Options	30,000	—	—	91
2020-08-19	Wijngaard Peter	Director	Award↑	Stock Options	30,000	—	—	60
2020-08-19	Block Timothy M.	Director	Award↑	Stock Options	30,000	—	—	91
2020-08-19	ADAMS THOMAS PHD	Director	Award↑	Stock Options	30,000	—	—	91
2020-08-19	BRANCACCIO JOHN P	Director	Award↑	Stock Options	30,000	—	—	91
2020-08-19	Cavan John T	Chief Financial Officer	Award↑ Filing footnotes — Stock Options (Direct) 53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.	Stock Options	160,000	—	—	381
2020-08-19	JACOB GARY S	Director	Award↑	Stock Options	30,000	—	—	93
2020-08-19	Foster Robert T	Director	Award↑ Filing footnotes — Stock Options (Direct) 70,667 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.	Stock Options	212,000	—	—	602
2020-06-25	Wijngaard Peter	Director	Award↑ Filing footnotes — Stock Options (Direct) 10,000 of the options vest on each of 6/25/2021, 2022 and 2023.	Stock Options	30,000	—	—	30
2020-06-10	Wijngaard Peter	Director	Other↑	No Securities Owned	0	—	—	0

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 57 transactions

Key facts CIK 1583771 CUSIP 426897401 Visit website Investor relations